Technical Analysis for NUVB - Nuvation Bio Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 3.22 | 0.94% | 0.03 |
NUVB closed up 0.94 percent on Wednesday, May 8, 2024, on 43 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | 0.00% | |
| New Uptrend | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.94% | |
| Narrow Range Bar | Range Contraction | 0.94% | |
| Outside Day | Range Expansion | 0.94% | |
| Wide Bands | Range Expansion | 0.94% | |
| Overbought Stochastic | Strength | 0.94% | |
| Stochastic Sell Signal | Bearish | 1.26% | |
| NR7 | Range Contraction | 1.26% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 13 hours ago |
| Down 3% | about 19 hours ago |
| Fell Below Previous Day's Low | about 19 hours ago |
| Down 2 % | about 19 hours ago |
| Down 1% | about 19 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio's proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world's leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Prostate Cancer
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Prostate Cancer
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.1598 |
| 52 Week Low | 0.95 |
| Average Volume | 1,646,271 |
| 200-Day Moving Average | 1.81 |
| 50-Day Moving Average | 2.76 |
| 20-Day Moving Average | 2.91 |
| 10-Day Moving Average | 3.05 |
| Average True Range | 0.22 |
| RSI (14) | 60.94 |
| ADX | 25.04 |
| +DI | 32.05 |
| -DI | 17.33 |
| Chandelier Exit (Long, 3 ATRs) | 2.78 |
| Chandelier Exit (Short, 3 ATRs) | 3.16 |
| Upper Bollinger Bands | 3.40 |
| Lower Bollinger Band | 2.42 |
| Percent B (%b) | 0.82 |
| BandWidth | 33.60 |
| MACD Line | 0.12 |
| MACD Signal Line | 0.09 |
| MACD Histogram | 0.0305 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.43 | ||||
| Resistance 3 (R3) | 3.41 | 3.31 | 3.40 | ||
| Resistance 2 (R2) | 3.31 | 3.26 | 3.33 | 3.38 | |
| Resistance 1 (R1) | 3.27 | 3.23 | 3.29 | 3.29 | 3.37 |
| Pivot Point | 3.17 | 3.17 | 3.19 | 3.19 | 3.17 |
| Support 1 (S1) | 3.13 | 3.12 | 3.15 | 3.15 | 3.07 |
| Support 2 (S2) | 3.03 | 3.09 | 3.05 | 3.06 | |
| Support 3 (S3) | 2.99 | 3.03 | 3.05 | ||
| Support 4 (S4) | 3.01 |
